A research team from MBG and iNANO at Aarhus University has used an in vitro selection technique to develop an RNA molecule that recognizes and binds the Spike protein from SARS-CoV-2 with very high specificity and strength. The hope is that the new molecule, known as an RNA aptamer, can help improve diagnostics and treatment of COVID-19.
![[Translate to English:] Figur](/fileadmin/_processed_/e/a/csm_JoergenKjemsFigurDK2_3be153695f.png)
